| Laura Vanderlinde, SLP | |
|
400 S 43rd St, Renton, WA 98055-5714 | |
| (425) 251-5165 | |
| (425) 656-4028 |
| Full Name | Laura Vanderlinde |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 400 S 43rd St, Renton, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174817274 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Vanderlinde, SLP 6117 N Atlantic St, Apt 2, Spokane, WA 99205-6274 Ph: (509) 280-7365 | Laura Vanderlinde, SLP 400 S 43rd St, Renton, WA 98055-5714 Ph: (425) 251-5165 |
News Archive
Researchers at The University of Texas MD Anderson Cancer Center have found that a protein involved in immune response to microbes also can fuel cancer development and suppress immune response to the disease.
A study published in this week's issue of the New England Journal of Medicine suggests that repeated topical use of products containing lavender oil and/or tea tree oil may cause prepubertal gynecomastia, a rare condition resulting in enlarged breast tissue in boys prior to puberty, and for which a cause is seldom identified.
PositiveID Corporation announced that it has reported financial results for the quarter ended March 31, 2010, its first full quarter of operations since its acquisition of Steel Vault Corporation in November 2009 and the resulting name change to PositiveID. The Company reported revenues of $673,000 for the first quarter of 2010, compared to revenues of $8,000 for the first quarter of 2009.
Protalix BioTherapeutics, Inc., announced today that the Company's New Drug Application (NDA) for taliglucerase alfa has been accepted for review by the U.S. Food and Drug Administration (FDA). The FDA granted taliglucerase alfa a standard review time of ten months, assigning a Prescription Drug User Fee Act (PDUFA) action date of February 25, 2011.
BRAIN AG, an European leader in white biotechnology and the global top 10 pharmaceutical corporation Bayer Schering Pharma AG co-operate in the field of production process optimisation of steroid compounds. The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds using optimised microbial production strains taking plant derived raw materials as starting material.
› Verified 8 days ago
Catherine A Mickelson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-251-5165 Fax: 425-656-4028 | |
Vanessa R Isom, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-251-5165 Fax: 425-656-4028 | |
Claire Engelbrecht, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Sw 7th St, Renton, WA 98057 Phone: 425-204-2285 | |
Erin Lafferty, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Sw 7th St, Renton, WA 98057 Phone: 425-204-2285 | |
Carol Moore, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Sw 7th St, Renton, WA 98057 Phone: 425-204-4865 | |
Sara E Jerger, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Sw 7th St, Renton, WA 98057 Phone: 425-204-3365 | |
Natasha B Arora, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3600 Lind Ave Sw Ste 170, Renton, WA 98057 Phone: 425-690-3513 Fax: 425-690-9513 |